The early findings from the U.S. study, announced Monday, are just one set of information AstraZeneca must submit to the Food and Drug Administration.
The early findings from the U.S. study, announced Monday, are just one set of information AstraZeneca must submit to the Food and Drug Administration.
AstraZeneca walked back its claim on how effective its COVID-19 vaccine was after top public health officials alleged the company..